Quarles & Brady Launches To Be or Not to 340B, a Health Law Blog
MILWAUKEE — The national law firm of Quarles & Brady LLP today announced that the firm’s Health Law Practice Group has launched To Be or Not to 340B, a blog that reports on news and legal developments in the 340B Drug Pricing Program.
"Our Quarles & Brady attorneys are active researchers in the health care field and provide high-level counsel regarding the challenges unique to the industry," said Sarah Coyne, co-chair of the firm's Health Law Practice Group. Roger Morris, the other co-chair, added, "To Be or Not to 340B aims to reach health care providers and other players in the health care industry with intelligent, well-considered discussions of cutting-edge topics and issues pertaining to the 340B program."
"We couldn't be more excited to launch To Be or Not to 340B," said Alyce Katayama, partner and regular contributor to the blog. "Our plan is to keep our clients informed by posting content to the blog, as well as our new 340B microsite on quarles.com."
The Health Law Practice Group provides innovative legal services to life science companies and other sectors of the health care industry. To subscribe to the blog, visit http://tobeornotto340b.quarles.com/.